Provention Bio Announces Top-Line Results from its Phase 1b PULSE Clinical Trial of PRV-300 in Patients with Moderate-to-Severe Ulcerative Colitis
Stock Information for Provention Bio Inc.
Loading
Please wait while we load your information from QuoteMedia.